Screening of factors inducing alveolar type 1 epithelial cells using human pluripotent stem cells
Stem Cell Reports, ISSN: 2213-6711, Vol: 19, Issue: 4, Page: 529-544
2024
- 5Citations
- 21Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations5
- Citation Indexes5
- Captures21
- Readers21
- 21
- Mentions1
- News Mentions1
- News1
Most Recent News
Constructing 'on-gel' alveolar organoids as a new screening platform
A study led by Professor Shimpei Gotoh (Department of Clinical Application), introduces a new culturing method to generate alveolar organoids suitable for medium- and high-throughput screening and identified several chemicals with synergistic effects on AT1 cell differentiation. The work is published in the journal Stem Cell Reports.
Article Description
Alveolar type 2 (AT2) epithelial cells are tissue stem cells capable of differentiating into alveolar type 1 (AT1) cells for injury repair and maintenance of lung homeostasis. However, the factors involved in human AT2-to-AT1 cell differentiation are not fully understood. Here, we established SFTPC GFP and AGER mCherry-HiBiT dual-reporter induced pluripotent stem cells (iPSCs), which detected AT2-to-AT1 cell differentiation with high sensitivity and identified factors inducing AT1 cell differentiation from AT2 and their progenitor cells. We also established an “on-gel” alveolar epithelial spheroid culture suitable for medium-throughput screening. Among the 274 chemical compounds, several single compounds, including LATS-IN-1, converted AT1 cells from AT2 and their progenitor cells. Moreover, YAP/TAZ signaling activation and AKT signaling suppression synergistically recapitulated the induction of transcriptomic, morphological, and functionally mature AT1 cells. Our findings provide novel insights into human lung development and lung regenerative medicine.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S221367112400047X; http://dx.doi.org/10.1016/j.stemcr.2024.02.009; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85189548920&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/38552636; https://linkinghub.elsevier.com/retrieve/pii/S221367112400047X; https://dx.doi.org/10.1016/j.stemcr.2024.02.009
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know